Mercury Laboratories Ltd.
| BSE: 538964 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE947G01011 |
| BSE 00:00 | 17 Sep | 700.50 |
-19.50 (-2.71%) |
OPEN
729.00 |
HIGH
729.00 |
LOW
700.00 |
| NSE 05:30 | 01 Jan | Mercury Laboratories Ltd |
| OPEN | 729.00 |
| PREVIOUS CLOSE | 720.00 |
| VOLUME | 85 |
| 52-Week high | 937.00 |
| 52-Week low | 366.00 |
| P/E | 14.95 |
| Mkt Cap.(Rs cr) | 84 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Mercury Laboratories Ltd. (MERCURYLABS) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 745.80 | -8.70 | -1.15 | 15823.68 |
| Cipla | 954.15 | 0.15 | 0.02 | 13900.58 |
| Dr Reddy's Labs | 4889.15 | -42.55 | -0.86 | 13349.10 |
| Sun Pharma.Inds. | 770.25 | -10.60 | -1.36 | 12803.21 |
| Lupin | 950.70 | -17.00 | -1.76 | 11055.93 |
| Apollo Hospitals | 4904.35 | 25.75 | 0.53 | 9153.00 |
| Cadila Health. | 557.95 | -6.30 | -1.12 | 7790.40 |
| Glenmark Pharma. | 519.25 | -16.00 | -2.99 | 7567.93 |
| Alkem Lab | 3833.55 | -35.20 | -0.91 | 7219.68 |
| Divi's Lab. | 5125.65 | -38.15 | -0.74 | 6798.61 |
| Torrent Pharma. | 3096.45 | -15.30 | -0.49 | 6450.83 |
| Ipca Labs. | 2496.15 | -73.75 | -2.87 | 5114.11 |
| Alembic Pharma | 776.85 | -6.35 | -0.81 | 5051.44 |
| Laurus Labs | 651.20 | 1.35 | 0.21 | 4768.72 |
| Abbott India | 20492.25 | -497.40 | -2.37 | 4310.02 |
| Gland Pharma | 3973.45 | -63.35 | -1.57 | 3462.88 |
| Glaxosmi. Pharma | 1540.70 | -34.30 | -2.18 | 3193.74 |
| Granules India | 327.90 | -5.05 | -1.52 | 3134.98 |
| Sanofi India | 7913.90 | -119.60 | -1.49 | 2901.90 |
| Ajanta Pharma | 2186.10 | -0.25 | -0.01 | 2718.59 |
Quick Links for Mercury Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
